Read this company snapshot
Daily valuation snapshot
Turn Therapeutics Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $12
- Market capitalization (USD)
- $357,456,480
- Price / earnings (TTM)
- Not reported
- Price / book
- 520.4
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TTRX in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TTRX in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing TTRX with another company.
| Daily close (USD) | $12 |
| Market capitalization (USD) | $357,456,480 |
| Price / earnings (TTM) | Not reported |
| Price / book | 520.4 |
No matching rows. Clear the filter to see all records.
Read TTRX's valuation metrics
Company size
Turn Therapeutics Inc. Common Stock's recorded market capitalization is $357,456,480. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TTRX's recorded price-to-book ratio is 520.4. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Turn Therapeutics Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about TTRX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TTRX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.